Skip to main content
. 2023 Dec 18;20(12):1177–1184. doi: 10.30773/pi.2023.0138

Table 1.

Demographic and clinical characteristics of study participants

Characteristics APOE ε4 non-carrier (N=95) APOE ε4 carrier (N=86) p
Age (yr) 75.9±6.8 75.6±6.3 0.739
Sex 0.054
 Male 43 (45.3) 26 (30.2)
 Female 52 (54.7) 60 (69.8)
Education years (yr) 9.8±5.6 11.6±4.6 0.021
Global FMM SUVRPONS 0.73±0.10 0.77±0.09 0.026
Cognitive function
 MMSE-K 23.1±4.3 24.1±2.9 0.067
 CERAD-K TM 22.6±7.0 22.2±6.8 0.659
 CERAD-K VF 10.6±3.8 11.9±3.5 0.016
 CERAD-K BNT 9.6±3.1 10.6±2.1 0.010
 CERAD-K CP 9.6±1.7 9.8±1.5 0.355
 CERAD-K CR 2.7±1.8 2.5±2.0 0.651
 CERAD-K total 52.5±12.1 54.6±9.8 0.194
 TMT B (s) 249.1±70.2 229.1±77.0 0.070
 Stroop Word-Color 26.0±10.1 27.6±10.6 0.294
BMI (kg/m2) 23.9±3.8 23.7±3.1 0.656
 <23 (normal) 39 (41.1) 35 (40.7) 0.980
 23–25 (overweight) 23 (24.2) 20 (23.3)
 >25 (obese) 33 (34.7) 31 (36.0)
SMI (kg/m2) 6.5±1.2 6.2±1.0 0.187
BFMI (kg/m2) 7.7±3.1 7.9±2.6 0.668
Visceral fat area (cm2) 96.9±41.2 101.2±37.4 0.470
Waist/hip circumference ratio 0.88±0.06 0.88±0.06 0.807

Values are presented as mean±standard deviation or number (%).

APOE, apolipoprotein E; SUVRPONS, standardized uptake value ratios of [18F]flutemetamol (FMM), using pons as a reference region; MMSE-K, the Korean version of Mini Mental Status Examination; CERAD-K, Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet; TM, Total Memory; VF, Verbal Fluency; BNT, Boston Naming Test; CP, Constructional Praxis; CR, Constructional Recall; TMT, Trail Making Test; BMI, body mass index; SMI, skeletal muscle index; BFMI, Body fat mass index